Lifeward Q2 revenue $5.7M (-15% YoY); net loss $6.6M; resets 2025 guidance

Lifeward Ltd.

2025-Q2 EPS reported -$1.05 revenue$10,758,000

Revenue $5.7M, down 15% YoY; traditional product revenue $2.5M (-19% YoY) excluding one-time Medicare benefit.
Net loss $6.6M ($0.58 per share) vs $4.3M ($0.50) in Q2 2024; includes $2.8M goodwill impairment.
Adjusted net loss $3.5M ($0.31 per share); cash burn improved to $3.9M from $5.6M prior year.
Record number of ReWalk units placed for Medicare since fee schedule; new CEO Mark Grant and CFO Almog Adar appointed.
FY 2025 guidance reset to revenue $24-26M and non-GAAP net loss $12-14M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.